Drug Price Hikes Unsupported By Evidence Cost US 815 Million ICER Report
| GCSSX Fund | USD 26.84 0.02 0.07% |
Slightly above 56% of Goldman Sachs' investor base is looking to short. The analysis of overall sentiment of trading Goldman Sachs Small mutual fund suggests that many investors are alarmed at this time. Goldman Sachs' investing sentiment can be driven by a variety of factors including economic data, Goldman Sachs' earnings reports, geopolitical events, and overall market trends.
Goldman |
The Institute for Clinical and Economic Review has identified five prescription drugs whose price increases in 2023 lacked sufficient clinical evidence to justify the hikes. Gilead Sciences Incs Biktarvy, Johnson Johnsons Darzalex, Novartis AGs Entresto, Exelixis Inc Cabometyx, and Pfizer Incs Xeljanz are among the five drugs flagged for unsupported price increases. These five drugs unsupported net price increases produce
Read at finance.yahoo.com
 |
Goldman Sachs Fundamental Analysis
We analyze Goldman Sachs' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Goldman Sachs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Goldman Sachs based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Position Weight
Cash Position Weight Comparative Analysis
Goldman Sachs is currently under evaluation in cash position weight among similar funds. Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Goldman Sachs Small Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Goldman Sachs mutual fund to make a market-neutral strategy. Peer analysis of Goldman Sachs could also be used in its relative valuation, which is a method of valuing Goldman Sachs by comparing valuation metrics with similar companies.
Peers
Goldman Sachs Related Equities
| GCGIX | Goldman Sachs | 0.26 | ||||
| GCGAX | Goldman Sachs | 0.00 | ||||
| GCGCX | Goldman Sachs | 0.00 | ||||
| GCGUX | Goldman Sachs | 0.00 | ||||
| GCEPX | Goldman Sachs | 0.35 | ||||
| GCEDX | Goldman Sachs | 0.35 | ||||
| GCEEX | Goldman Sachs | 0.35 | ||||
| GCEBX | Goldman Sachs | 0.36 | ||||
| GCEGX | Goldman Sachs | 0.36 | ||||
| GCEJX | Goldman Sachs | 0.47 |
Other Information on Investing in Goldman Mutual Fund
Goldman Sachs financial ratios help investors to determine whether Goldman Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goldman with respect to the benefits of owning Goldman Sachs security.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |